Joint Pain Injections Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Joint Pain Injections Market is segmented by Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, and Others), Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Joint Pain Injections Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Joint Pain Injections Industry Overview

The global joint pain injections market is fragmented in nature due to the presence of many companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known. Some of the key market players are Anika Therapeutics, Inc., Zimmer Biomet, Bioventus LLC, Ferring B.V., sanofi-aventis LLC, Pfizer Inc., Eli Lilly and Company, Flexion Therapeutics, Inc., and Teva Pharmaceuticals among others.

Joint Pain Injections Market Leaders

  1. Zimmer Biomet

  2. Anika Therapeutics, Inc.

  3. Bioventus LLC

  4. Ferring B.V.

  5. sanofi-aventis LLC

  6. *Disclaimer: Major Players sorted in no particular order
Joint Pain Injections Market Concentration

Joint Pain Injections Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?